Maravai LifeSciences Holdings Inc (MRVI)
8.20
+0.35
(+4.46%)
USD |
NASDAQ |
Apr 30, 16:00
8.20
0.00 (0.00%)
After-Hours: 19:25
Maravai LifeSciences Holdings Free Cash Flow (Quarterly): -9.009M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -9.009M |
| September 30, 2023 | -1.661M |
| June 30, 2023 | -5.865M |
| March 31, 2023 | 77.21M |
| December 31, 2022 | 93.12M |
| September 30, 2022 | 103.59M |
| June 30, 2022 | 162.62M |
| March 31, 2022 | 159.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 53.09M |
| September 30, 2021 | 104.23M |
| June 30, 2021 | 161.41M |
| March 31, 2021 | 34.99M |
| December 31, 2020 | 70.58M |
| September 30, 2020 | 41.34M |
| June 30, 2020 | 8.556M |
| March 31, 2020 | 6.304M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.009M
Minimum
Dec 2023
162.62M
Maximum
Jun 2022
66.25M
Average
61.83M
Median
Free Cash Flow (Quarterly) Benchmarks
| ModivCare Inc | -36.79M |
| Dyadic International Inc | -0.9234M |
| Enveric Biosciences Inc | -1.751M |
| Monopar Therapeutics Inc | -1.546M |
| SeaStar Medical Holding Corp | -4.485M |